Omnicell Reports Results for Fiscal Year and Fourth Quarter 2018
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/8/2026
- S&P 500 falls as AI worries hit software makers
- Brent crude hits six-week high near $97 as Houthi strike targets Saudi Aramco
- Qualcomm stock surges 9.5% on Amazon AI deal & 25M share warrant
- Energy stocks rise premarket as oil prices climb on Middle East supply fears
- Novartis shares plunge 10% as failed drug trial clouds growth outlook
- Harry and Meghan surprised by King Charles' letter on their status
- Citi initiates UiPath coverage with Buy rating and $23 target
- S&P 500 falls as AI worries hit software makers
- WestPark Capital Starts Akebia Therapeutics (AKBA) at Buy
- After an 18% summer selloff in chip stocks, Citi asks what comes next
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Omnicell (OMCL) PT Raised to $70 at Piper Jaffray
February 8, 2019 8:50 AM ESTPiper Jaffray analyst Sean Wieland raised the price target on Omnicell (NASDAQ: OMCL) to $70.00 (from $59.00) while maintaining a Neutral rating.
... MoreOmnicell (OMCL) Tops Q4 EPS by 3c, Revenues Miss; Offers Q1 & FY19 EPS Mid-Point Guidance Above Consensus, Q1 Revenues Guidance Below Consensus, FY19 Revenue Outlook Tops Views
February 7, 2019 4:36 PM ESTOmnicell (NASDAQ: OMCL) reported Q4 EPS of $0.70, $0.03 better than the analyst estimate of $0.67. Revenue for the quarter came in at $211.8 million versus the consensus estimate of $215.4 million.
"With the launch of our Autonomous Pharmacy vision at ASHP Midyear, health system pharmacists are... More
